In the Era of Neoadjuvant Chemo-Immunotherapy for Resectable Locally Advanced Stage III NSCLC, Neoadjuvant Chemoradiotherapy Is No Longer a Standard of Care.

Authors

Bianca Battilana, Matthias Guckenberger, Andreas Wicki, Isabelle Opitz

Published in

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. Volume 21. Issue 9. Pages 103946.

PMID:
42697608
Bibliographic data and abstract were imported from PubMed on 05 Sep 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.